| October 17, 2007 |
| October 17, 2007 |
| October 2007 |
| |
| Resolution of middle ear fluid by pneumatic otoscopy [ Time Frame: 2 months ] |
| Same as current |
| No Changes Posted |
| acoustic reflectometry, tympanometry, reflux symptom questionnaires [ Time Frame: 2 months ] |
| Same as current |
| |
| A Clinical Trial of Proton Pump Inhibitors to Treat Children With Chronic Otitis Media With Effusion |
| |
This study is being done to see if reflux of stomach fluid might be a cause of chronic fluid in the ears. Our hypothesis is that treatment with an anti-reflux medication (lansoprazole) will increase the rate of resolution of chronic middle ear fluid in children. |
This study is being done to see if reflux of stomach fluid might be a cause of fluid in the ears. Earlier studies have found pepsin or pepsinogen, a component of stomach fluid, in the middle ear fluid of many children with chronic middle ear fluid. Anti-reflux medicines called proton pump inhibitors (PPI) reduce the acidity of the contents of the stomach and the activity of pepsin or pepsinogen. We are studying the effectiveness of a PPI called lansoprazole (Prevacid™) in reducing fluid in the ears. If lansoprazole is able to reduce the fluid in the middle ear, this tells us that the reflux of gastric acid into the esophagus and into the ear canal may be causing middle ear fluid. |
| |
| Interventional |
| Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Efficacy Study |
| Otitis Media With Effusion |
| Drug: lansoprazole |
- Experimental: Prevacid SoluTab (15 or 30 mg tab) once daily for 2 months
- Placebo Comparator: Placebo SoluTab once daily for 2 months
|
- Lieu JE, Muthappan PG, Uppaluri R. Association of reflux with otitis media in children. Otolaryngol Head Neck Surg. 2005 Sep;133(3):357-61.
- Tasker A, Dettmar PW, Panetti M, Koufman JA, P Birchall J, Pearson JP. Is gastric reflux a cause of otitis media with effusion in children? Laryngoscope. 2002 Nov;112(11):1930-4.
- Abd El-Fattah AM, Abdul Maksoud GA, Ramadan AS, Abdalla AF, Abdel Aziz MM. Pepsin assay: a marker for reflux in pediatric glue ear. Otolaryngol Head Neck Surg. 2007 Mar;136(3):464-70.
- Sone M, Yamamuro Y, Hayashi H, Yanagi E, Niwa Y, Nakashima T. Prediction of gastroesophageal reflux in otitis media with effusion in adults. Acta Otolaryngol. 2007 May;127(5):470-3.
|
| |
| Enrolling by invitation |
| 144 |
| October 2008 |
|
Inclusion Criteria:
- History of chronic otitis media with effusion meeting clinical indications for tympanostomy tubes placement, defined as the presence of middle ear fluid on physical exam for at least 3 months, in at least one ear.
Exclusion Criteria:
- Past medical history or concurrent conditions known to increase the incidence of either recurrent otitis media or otitis media with effusion or gastroesophageal reflux disease, including cleft palate, neurological delay, cerebral palsy, Down syndrome, velocardiofacial syndrome, and primary ciliary dyskinesia.
- Children with structural abnormalities of the tympanic membranes, such as cholesteatoma, deep retraction pockets, and atelectasis of the tympanic membrane. These abnormalities would require placement of tympanostomy tubes in standard clinical practice.
- Children weighing less than 10 kilograms, due to the lower weight limit for standard Prevacid™ dosing
|
| Both |
| 2 Years to 12 Years |
| No |
| Contact information is only displayed when the study is recruiting subjects |
| United States |
| |
| NCT00546117 |
|
| HRPO# 07-0762 |
| Washington University School of Medicine |
- Doris Duke Charitable Foundation
- TAP Pharmaceutical Products Inc.
|
| Principal Investigator: |
Judith EC Lieu, MD |
Washington University School of Medicine |
|
|
| Washington University School of Medicine |
| October 2007 |